Shopping Cart
- Remove All
- Your shopping cart is currently empty
Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator (SERM) with a fixed ring structure similar to raloxifene. It exhibits potent antiestrogenic effects on breast cancer and endometrium with minimal side effects and provides beneficial estrogenic effects on bone health and lipid profile.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator (SERM) with a fixed ring structure similar to raloxifene. It exhibits potent antiestrogenic effects on breast cancer and endometrium with minimal side effects and provides beneficial estrogenic effects on bone health and lipid profile. |
In vitro | Arzoxifene decreases the expression of estrogen receptors in endometrial cancer cell lines (ECC-1)[1]. |
In vivo | Arzoxifene effectively suppresses the growth of MCF-7 breast cancer xenografts in oophorectomized athymic mice and has been documented to halt body weight gain in oophorectomized rats [1]. |
Alias | SERMIII, LY353381, Arzoxifene |
Molecular Weight | 475.6 |
Formula | C28H29NO4S |
Cas No. | 182133-25-1 |
Relative Density. | 1.234 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.